Belgian Court Backs Generic Clawback Exemption Against Brand Industry Challenge
Executive Summary
Belgian off-patent industry association Medaxes has welcomed a court decision to reject a brand industry challenge over the exemption of generics from the country’s pharmaceutical clawback tax.
You may also be interested in...
Belgian Initiative Raises Awareness
Belgium’s Medaxes off-patent industry association has run a Generic Medicines Day to raise public awareness of the benefits of generics, as well as the obstacles that the industry faces.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.